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Los An&?& Colifirniu 
111 (%n) rntimyosin antibody~“pt&e was shldied by inducing 
mywrdial iolarction in I8 dwa, 8 with &sad chest let? anterior 
dcxmdbg artery balloon w&.&n for 3 h followed by repwfu- 
sioo (em”@ A) md 10 does with oven chest left ante&r dewend- 
bg arttry ligath (without rqe&sion, gmup B). 
Backgnwmd. The r lation ofantimytin ““t&c to myocardiPl 
injury hm been docunnoted. However, its relation to tracer 
&livery by myucxdial blood Row has not been studied and has 
been a~umed to be lndepestdent. 
Methods. lmhmlll antimyosin antibody, 2 mCi, was in- 
jected 20 lolo vher repwfmkn and 3 b aRer romnary artery 
Ugatloa In grmps A and B, t’espectively. Regional blcmd flows 
mm determined bv mdidsbded micmmheres durbte wbtsion 
andl4htaterinb&grqs. Onday 1, dagswrekillpd at&risk 
zone delineatii with goatian videt. The heart was excised and 
stained with hipbayltetm”llum chbrkk Edution and graded for 
btcreaslng severity of t&e injury basal on extent of staining. 
Micmspbere activity and “‘IO attlimyaitt activity were measured 
ln mtltml tissue (grade 1). n”ldnf”rct tissue at risk @“de Z), 
With the advent of therapeutic interventions restoring blood 
Row during acute myocardial infarction. the need for accu- 
rate noninvasive tests to assess the extent of myacardium 
rendered viable and necrotic has become essential. Total or 
42; p x o.osgmup A vs. g4p Bj, abi.23 bad tower Mood Bow 
on day 2 10.51 2 0.36 vs. 0.2, vs. 0.u: p 4 0.01). N 
“‘I” ant~myosin activity for Mood Bow on d”y 2 rsslled in 
quiva’mt “‘In ardimymkt uptake la infarct t&e (32.6 f 21.6 
vs. 36.6 + 29.8 for group A vs. gmup B: p = NS). 
serve s asuit”bletraceriw b&cl sizbtg if~yocnrdislbbxdtlon 
in the same rqlon yiel‘e f&wed simultulmury. 
(1 Am Cdl C”n!ial1993;21:23~9) 
peak creatine kinase nzyme measurements have not proved 
to be reliable indexes for measuring the extent of necrosis 
because of wiable clearance rates and are associated with 
greater e*“r after repelfusion (I-3). 
Scintigraphic srudies (4-6) utilizing technetium-99 Pyle 
phosphate and thalli”m-201 in conjunction with single- 
photon emission computed tomwphy have demonstrated 
an acceptable degree ofaccuracy in estimation of infarct size 
but generally tend IS overestimate the extent of necrosis in 
repafused canine infarL:bn model. 
Thus. use of indium-I II (“‘In! monoclonal antimyosin 
antibody for locating and assessir.g the extent of necrosis 
during ac”te myocardial infarction has recently been pro- 
moted by several studies (7-l I). The improved accumcy of 
this tracer compared with that “f pyrophosphate in estimat- 
ing myocardial mfarct size has been attributed to its higher 
specificity and mdependence af tracer uptake from bled 
Row (12-15). However, although the high specificity of “‘In 
antimyosin antibody has been repeatedly demonstrated, the 
independence of antimyosin tracer uptake to blood flow 
remains lo be verified. Most animal studies have been 
perfomred utilizing canine models that are known to possess 
considerable collateral flow. In the only experimental study 
in which permanent ligation of the &o&y vessel w& 
involved (a nonreoerfused model), antimyosin uptake was 
indeed reduced f& a commensurate extent of myocardiil 
iniurv when cornoared with the reoerfilsed model (13). In -- I 
humans, the ind.$endeace of blo& flow from antimyosin 
uptake has been advocated on the basis of uptake of the 
tracer in patients with an occluded infarct-related artery and 
lack of collateral flow by angiography, a technique known to 
be insensitive for revealing collateral perfusion. 
The majority (S,lO,ll) of clinical trials have studied 
patients who have received thrombolytic therapy wiril reper- 
fusion. Closer scrutiny of these data reveals that a substaa- 
tial portion of patients with antimyosin uptake despite an 
occluded vessel and lack of collateral flow by angiogmphy 
have a creatine kinase level <i,wO IU, which is consistent 
with a nontransmud i&&n and suggests the persistrw 
of residual blood flow. In addition, several patients deman- 
strated no uptake of anfimyosin, for which there is no 
apparent explanation. 
Thus, we chose to study systematically the flow depen- 
dence of “‘Jo antimyosin antibody uptake in dogs with 
experimentally induced myocaidial infarction with and with- 
ou reperfiis1on. 
Methods 
Summary of Protocol 
On day I, I8 dogs (8 in group A [reperfused model1 and IO 
in group B [nonreperfused model]) were anesthetized. Group 
A dogs underwent closed chest left anterior descending 
anery balloon induction of infarction with reperfusion after 
3 h. Gxmp B dogs underwent open chest permanent ligation 
of the left anterior descending artery without reperfusion 
(see following sections for details). Indiumlll antimyosin 
was injected intravenously 20 min after reperfusion or 3 h 
ef!er left anterior descending artery ligation. The thoracot- 
omy was closed in g:oup B dogs and all animals were 
allowed to recover. On day 2, all animals were reanesthe- 
tized and underwent a left thoracotomy. After microsphere 
blood Row measurement hrough a left attial line injection, 
the risk zone induced on day I was delineated with gentian 
violet dye before the heart was excised, sliced aad stained in 
triphenyltetrazolium chloride (16). Tissue was graded for 
severity of necrosis and assayed for microsphere (17) and 
“‘10 activity. 
Anixal Preparation and Infarct Induction 
Model with reperfwion. In group A. eight mongrel dogs 
weighing 19 to 27 kg were studied after a 12-h overnight fast. 
On day I of the study protocol, the dogs were anesthetized 
with intravenous sodium thiamylal (20 mg!kg body weight), 
intubated and ventilated by a Harvard Apparatus respirator 
with a mixture ofM)% oxygen and 40% nitrogen to maintain 
an arterial partial pressure of oxygen (Pa03 between 95 and 
I50 mm Hg. Halothane was added to maintain anesthesia. 
The left femoral and right carotid arteries were exposed by 
means of a cutdown and cannulated. A polyvinyl catheter 
was inserted into the thoracic aorta through the left femoral 
artery and was used to measure blood pressure with use of a 
Statbam P23 Db pressore transducer (Gould, Inc., Cardio- 
vascular Products). Continuous electrocardiographic (ECG) 
monitoring of limb lead II and arterial blood pressure was 
recorded on an eight-channel GoaId Brush recorder (Gould 
Recording Systems). A modified 7F Judkins right coronary 
artery angiography catheter was advanced through the right 
carotid anery under Auoroscopic guidance and positioned to 
cannulate selectively the left coronary ostium. A 3F Fogarty 
balloon catheter was passed through the Judkins catheter 
into the left anterior descending coronary artery, so that the 
dais; tip “i me baiioon was iocated proximal to the first 
diagonal branch. The balloon, filled with contrast medium. 
was inflated for 3 hand inflation was verified wriodicallv hv 
fluoroscopy. A pigtail catheter was advattckd into thk left 
ventricle through tix left femoral artery and cobalt-57 or 
niobium-95 microspheres were i&ted to measure blood 
flow during IeIi anterior descending coronary artery occlu- 
sion. Between 500,ORl and 5 million micmspheres, approx- 
imately 150 mm in size, were injected on the basis of decay 
correction for radioactivity and specilic activity (Dupont). 
Reperfosion was achieved by balloon deflation. Twenly 
minutes after reperfusion, “‘In-labeled mutine myosin 
monoclonal Fab amibody (2 mCi) (Centocor) was injected. 
Binding of the indium label to antibody was verified by thin 
layer chromatography to be >95% before injection. The 
cannulated carotid and femoral arteries were ligated and 
incisions sutured. The dogs were then allowed to recover. 
Model witlwu~ rq&asion. In group B, 10 mongrel dogs 
weighing 19 to 24 kg were studied. On day I of the protocol 
the dogs were anesthetized with sodium thiamylal(20 mplkg) 
and ventilated on room air (Volume Cycle Harvard Respim- 
tar). The left femoral artery was exposed and cannulated 
with an SF hemaquet. Continuous ECG and arterial blood 
pressure was recorded, as listed earlier. A left thoracotomy 
was performed and the heart suspended in a pericardial 
cradle. The left atrium was eannulated with a polyvinyl 
tubing catheter through the letI auricle. The left anterior 
descending artery was dissected free immediately proximal 
to the first diagonal branch and ligated. Cobalt-57 or 
niobium-95 microspheres were injected into the let7 atrium to 
measure blood flow during occlusion. Indium-II l-labeled 
amimyosin antibody (2 mCi) was then injected intravenously 
3 h after ligation. The thoracotomy incision was sutured. 
with the left atrial line and chest tube extending from the 
incision. Air war removed through the chest tube by aega- 
tive air pressure until a vawam seal was achieved. The 
femoral artery was ligated and ihe incision sutured. The dogs 
were then allowed to recover. 
Tissue Analysis 
Delineation of rtsk and contml zone myocardium. On day 
2, both groups of dogs were anesthetized agam and venti- 
lated, as described earlier. The right femoral artery was 
exposed and cannulated for continuous blood pressure mon- 
itoring. The ECG was recorded as before and a left-sided 
thoracotomy was performed. In the dogs with reperfusion 
(group A), a polyvinyl catheter was inserted into the left 
atrium (already present in group B [dogs without rcperfu- 
sion]). Cobalt-57 or niobium-95 microspheres were then 
injected into the left atrium to measure reperfusion blood 
flow (in group A) or late occlusion blood flow (in group 8). In 
group A. the left anterior descending coronary artery was 
dissected ttze at the site of previous balloon infla!ion. which 
was readily appmnt by &tivascular edema and hemor- 
rhage, and then liited. Gentian violet or monastral blue dye 
was then injected into tin: left atrium to delineate the 
myocardial perfusion tcrrhory‘a~sred by the coronary oc- 
clusion from day L (designated control zone). The remainder 
of the left ventricle (unstained by blue dye) was designated 
aa the risk .xme. The heart was then excised and sliced into 
cross sections perpendicular to the long axis of the heart. 
Triphenyltelra&ium chloride stain& Cross-sectiona! 
slices (I cm thick) from all dogs were submersed in triphenvl 
tetmwiium chloride stain& solution for 20 min. ‘Cm&- 
sectional slices were cut intv sections weighing approxi- 
mately I g from endowdial and epicardial portions of the 
myoc&di~m and inserted in a preweighted test tube for 
scintillation countina of “‘In and microwhere count activ- 
ity. Before count&, all tissue s&ions were assigned a 
tissue grade based on triphenyltetmzolium chloride and 
gentian violet stain as follows. Grade I represented nonuti 
tissue myocardium in the control zone manifested as geniian 
vi&t dye plus triphenyltetrarolium chhride (brick red) 
stain. Grade 2 represented noninjured tissue in the risk zone 
(brick red and without gentian violet dye). Grade 3 tissue 
was defined as tissue in the risk zone with speckles of 
unstained tissue representing an admixture of viable (tri- 
phenyltetrazolium chloride-stained) and necrotic (tri- 
phenyltetrazolium chloride-unstained) tissue. Grade 4 tissue 
represented necrotic tissue only (all unstained) and grade 5 
represented necrotic tissue with gr-- :y visualized hemor- 
rhage. 
Meuurewnt ef tissue aciivtty cencontratten. A multi- 
channel analyzer was used fo; the following windows. 
Indium-1 II activity was initially measured in I71 to 245 keV 
energy peak and followed 3 weeks later (to allow complete 
decay of “%I activity) by measurement of microsphere 
count activity in the 122 to 136 keV range for cobalt-57 and 
700 to 800 keV energy peak for niobium-95. 
Data Analysis 
Mean values for cow! activity of “‘In-labeled antimyo- 
sin (range 2,wO to 2 million countslmin) and microsphere 
counts were uomtaliied to mean counts in tdphenyltetn- 
zolium chloride grade I or normal tissue. Mean ratios (SD) 
of counts are given and were correlated with tissue injury 
expressed by the triphenyltetrazolium chloride grade. Group 
data (count activity ratios) at different triphenyltetrazolium 
chloride grades were compared by analysis of variance 
followed by the unpaired Student I test. Count ratios in 
models with and without reperfusion within a triphenyltct- 
ruzolium chlonde grude were compared by unpaired Student 
I test. 
All studies conformed and complied with the “Position of 
the American Hean Association on Research Animal Use” 
adopted by the Association on November II. 1984 
ReSUltS 
Eight dogs were subjected to closed chest repafusion 
after 3 h of balloon occlusion and are referred to as the dogs 
with reperfusion or group A. Ten dogs underwent open chest 
pem~auent mid-left anterior descendicg coronary artery ii- 
@ion and are referred to as the dogs without reprfusion or 
WUP B. 
Hemodynamic varWes. Table I lists the mean heart 
rate-blood pressure product before occlusion, duringoeclu- 
sion and approximately 20 h after reperfusion in group A 
dogs and after ligation in group B dogs. No statistical 
significance was noted. thus confirming that workload of the 
myocadium (a determinant of myocardial blood flow) did 
not differ significantly betwen the two groups of animals. 
Myoadialbkwdllowverswsewityeftisvueir&y. 
Table 2 lists the messuremeuts of ntyocardial blood flow 
immediately after occlusion for groups A and B and 20 h 
after reperfusion or ligation, respectively. Myoardial blood 
flows are expressed as a ratio between microsphere count 
activity in ischemic tissue and the mean of activity in noonal 
tissue. In each group of animals. the mean value of myocar- 
dial blood Row in tissue of increasingly severe ischemic 
injury (triphcnyltettazolium chloride grades I to 5) is listed. 
Figure IA illustrates the relation of myocardial blood flow 
during occlusion to tissue ischemic injury in group A With 
wetfusion) to erouo B Without rcoerfusionh Myocxdial 
b&d Row ratio was &&ntally &ced whh inc&singly 
severe triphenyltetrazolium chloride grade (p c 0.001 myo- 
cardial blood flow ratio in tissue grades 3 to 5 vs. grade I in 
group A and tissue grades 3 and 4 vs. grades 1 and 2 in group 
B). Figure IB demonstrates that myocardial blood Row 
during reperfusion (group A) returns toward the level ob- 
served in normal tissue (triphenyltetrezotiom chloride tissue 
grade 1) but remains slightly decreased in grade 4 and grade 
5 tissue containing hemorrhagic infarct (p < 0.05). In con- 
trast, blood flow remained markedly reduced in the group B 
dogs without reperfusion (p < 0.01 for myocardial blood flow 
&o in grade 4 tissue vs. grades 1, 2 and 3). No grade 5 
tissue was noted in the erooo B does. Mvomdial blood Row 
ratio in grade 4 tissue&s si&cantly lower in group B dogs 
as compared with group A dogs (p 4 0.05). 
Ftegtonal “‘In antimyrain antibody tracer uptake versus 
severity of tissue injury. Figure ZA plots the uptake of “‘In 
antimyosin activity (expressed as a ratio of count activity in 
normal tissue) with increasing severity of tissue injury. In 
reperfused myocardium, count activity (normalized for tis- 
sue weight) correlated well with the degree of tissue injury 
with a signal ratio I4 times greater (14.6 t 0.8) in infarct 
tissue than in normal tissue. In contrast, in group B dogs, 
which had a similar grade macroscopic tissue injury and 
blood flow attenuation during ischemia but reduced blood 
flow at the time of antimyosin injection, “‘In activity was 
approximately half of that in rep&used tissue of commen- 
surate triphenyltetrazolium chloride tiswe grade (5.5 f 1.9 
vs. 3.8 + 2.4, p < 0.05 for tissue grade 3 and 10.6 * 5.1 ! s. 
5.0 f 4.5, p < 0.05 for tissue grade 4 in group A vs. B). 
To verify that “‘In antimyosin tracer uptake was depen- 
dent on blood flow at the time ofinjection, count activity was 
norrna:ized to microsphere blood flow count activity and 
relatrr. to normalized activity in triphenyltetrazolium 
chloride I (1.0 by definition). Figure 26 demonstrates the 
relation of antimyosin antibody uptake to triphenyltelra- 
zolium chloride-graded ischemic injury when normalized to 
blood flow (p = NS fore!! time !&dies comparing group A 
and group B). The nornxalized uptake of antimyosin remains 
significantly increased in infarct tissue in comparison with 
nornxil tissue for hoth group A and 6 adrnals (32.6 f 21.6 
and 36.6 f 29.8 vs. 1.0 f 0.0, respectively, p < 0.05). Thus. 
plyre I. Mean myocardiat blood Row (MRFJ expressed as a ratio 
of normal tissue Row tordkrate) in group A dogs With reprfusion. 
black bara) and gmup B dogs Without reperfusion, widte barn))) Tbe 
absckrs shows increasing tissue injury as graded by triphenyltctra- 
zolium chloride (TIC) stain (see Methods). A, During wclusion, 
flows are similarly reduced in the two animal groups at each grade of 
tissue injury. At injury grades 3 to 5, flow in group A is significantly 
reduced compared with Row at grade 1 and in group R it is 
significantly reduced compared with flow BL grades I and 2. 
B, Values on day 2 (during repeifusion i  group A and in the absence 
of reperfusion i group Bl. Blood flow in group A dogs returnS to 
grade 1 tissue levels but remains lightly depressed at tissue gmdes 
4 and 5. Flow in group B dogs remains markedly depressed at tissue 
grade 4 compared with that at grades 1.2 and 3 and is significantly 
lower than that in group A dogs. All values are expressed as mean 
value f SD. *+p < 0.0s. “p < 0.01. 
a closer approximation of the relation of antimyosin activity 
to tissue injury is achieved when corrected for the effects of 
blood flow dependence (tracer delivery) of antimyosin up 
take. 
Discussion 
Our results demonstrate that “‘In antimyosin antibody 
activity in the eight animals (group A) that underwent 
reperfusion after a 3-h coronary artery occlusion had uptake 
of “‘In antimyosin that correlated well with the extent of 
Fii2. A, lndium-Ill (In-tll) antimyosinacdvity (expressed asa 
normalized ratio to counts in control tissue) (ordinate) versus 
triphenykerraxdium chloride flTC) tissue injury grade (abseisa) in 
group A dogs (with reperfusion. black hers1 and group B dogs 
(without reperfusion. white bus). Indium-Ill antimyosin acdvhy 
increases with increasing ischemic injury in group A and follows a 
similar trend in group B. although it remains attenuated compared 
with that ingroup A. ‘p < 0.05 comparing roups A and B at grades 
3 and 4. 6, Similar to A except hat indium-I It count acdvily is 
normalized for day 2 microsphere-meawed blood flow in the two 
groups. Indium-Ill count activity at each tissue grade is similar in 
the two groups when normalized for blood Row Cp = NS by unpaired 
I test). 
iscbemic injury. The specificity of this tracer as a marker of 
necrosis is excellent with a signal ratio 14 times greater in 
necrolic than in control tissue. In contrast. the IO animals 
(group B) that did not undergo repetfusion (despite the 
iocre&sed ~ol!~!eral f ow present in the canirle model) had 
markedly attenuated uptake of “‘In anttmyosin d&&g 
corrected for tissue weight for an equivalent grade of ne- 
crotic tissue by tetrazolium triphenykhloide (lriphenyltet- 
razotium chloride) stain. However, despite this attenuated 
uptake of “‘In antimyosin in nonreperfused tissue, the 
specificity of antimyosin marker persisted with an average 
fivefold greater signal ratio in necrotic t%sue versus control 
tissue. Additiwel support for the higb speciiicity of this 
marker IS demonstrated by the three- to fivefold uptake of 
“‘In antimyosin in triphenyltetrazolium chloride grade 3 
tissue (mined viable and nonviable) compared with that ia 
normal tissue. Such tissue (txiphenyitetrazolium chloride 
grade 3) is unlikely to demonstrate the presence of infarct 
tissue based on other scintigraphic or clinical indexes. 
Howver. in addition to the speciicity of “‘In aotimyosin 
as a marker of necrosis, our results, unlike previous assump 
t!ons. demonstrate that sp?ake of this tracer is dependent on 
blood Aow. When “‘In antimyosin cotmts were normalized 
for blood Row delivery to the tissue at the time of “‘In 
antimyosin incorporation. activity was equivalent in similar 
triphenylwrazolium chloride grade tissue for both groups of 
animals. Thus. our data verify that 24 h afterinjectioa, “‘In 
antimyosin tracer optake is blood flow dependent. 
Limitations of the shtdy. Venous tracer kinetic studies by 
Johnson et al. tlli and Belier et al. (18) demonstrate that 
serum clearance of “‘1” antimyosin shows a decrease in 
blood activity to IS% of initial activity in 24 hand a further 
decrease to 5% in 48 h. Khaw et al. (13) have shown that 48 
to 72 h is occasionally required before blood activity is 
cleared Thus. it is possible but unlikely that ifour study bad 
implemented a longer input function with the animals killed 
and “‘ln activtty measured 48 h after antimyosin injection 
(vs. the 24 h used in our protocol), count activity for 
similarly graded tissue injury in the reperfused and nonreper- 
fused animals would be more comparable. However, esti- 
mation of infarct size based in “‘In antimyosin activity 
irrespective of flow to region of activity would be erroneous 
if scans are performed at 24 h. as done in the recent 
multicenter clinical trials (7). 
Because only a few doas in each WUD undewem “‘In 
gamma scintig&by, we &not cot&e our findings of 
:issne scintillation counting with the imagz results. How- 
ever. counts measured by the former method are not subject 
to whole body attenua~on problems. and thus the t&e 
scintillation counts used in our method probably yielded a 
more reliable quantitative measure of tracer uptake. 
Comparison with other studies. Though the timing of 
antimvosin administration was db%rent in the study by 
Merh; ct al. (19). in which the tracer was injected d&i6 
occlusion, a similar increase in antimyosin uptake was noted 
in necrotic tissue of animals with reperfuaios. However. 
uptake oi antimyosin in necrotic tissue of animals without 
r&e&ion in the latter study was atteauated to ihe extent of 
bcinn unable to distinenish necrotic from viable tissue. In 
contrast, our resttlts show a persistent increase in antimyo- 
sin uptake. although relatively attenuated compared with 
!hst of rewrfused tissue in the animals without repetfusion. 
The explanation of this discrepancy in antimyosin uptake of 
nonreperfuxd tissue is oat obvious. Earlier administration 
of the tracer in the dogs without reperfusion (75 vs. 180 min) 
cannot explain this discrepancy because of the slow clear- 
ance and prolonged input function of the tracer (>24 h). 
Our results give further insight into those obtained by 
permanently occluded infarct-related artery has been assu- 
&ted with increased cardiac Mmplications consistent with 
clinical observations in patients with low antimyosin uptake 
in the infarct territory. 
The repeatedly demonstrated high specificity of “‘In 
antimyosin us a marker of necrosis warrants further investi- 
gations with this tracer. The potential drawback of this 
tracer is its slow clearance from the blood pool, which 
necessitutes a delay in imaging and assessment of ischemic 
injury size in the setting of acute infarction. Variation in 
radioligand chelating agents could obviate this pmblem and 
preliminary results have been encouraging (23). 
cot~eciion for variation of blood flow in patients with myo- 
cardial infarction. Such a combined approach may allow the 
Concluslutts. Indium-1 I1 antlmyosin represents a highly 
specific tracer for the E?lineation of acutely necrotic myo- 
cardium, which resulr. in high contrast of radioactivity 
concentration between necrotic and normal myocardium. 
However, the intensity of tracer uptake and infarcted myo- 
cardium depends on blood flow and thus tracer delivery, as 
demonstrated in this experimental study. Methods attempt- 
ing to quantify infarct size with “‘In antimyosin will require 
Antunes et al. (9) in which patients with a Q-wave myocar- 
dial infarction underwent imaging 48 h after antimyosin 
injection. Approximately 2.5% ofpatients demonstrated faint 
or no uptake of “‘In antimyosin. We presume that these 
patients had little residual Row to the infarct region, resulting 
in attenuated uptake. 
Our results in the experimental setting explain those 
noted in the clinical setting of the multicenter trial of 
antimyosin imaging in patients with acute tmnsmural myo- 
cardial infarction (7). In the latter trial, intensity of antimy- 
osin uptake on scintigmphy was correlated with patency of 
the infarct-related vessel and the presence of collateral ROW 
by angiography. Similarly, “‘In antimyosin tissue sample 
activity, which is a correlate of “‘In activity on scintigraphy 
rather than extent of defect size. was reduced in animals 
with permaneut ligation of the left anterior descending 
artery. However, other factors in addition to the ratio of 
blood Row to tracer delivery may play a role in determining 
the intensity of myocardial uptake. 
of left ventricular dysfuiction remains th;m&t important 
risk factor in oatients with coronarv arterv disease (20). It is 
Clinical rde of antimvusin ~nlihcdy lm&nr. The extent 
therefore assimed that assessing il;farct s&e iit patients with determiuation of tracer retention fraction as an index of 
acute myocardial infarction would yield a more accurate infarct tissue. The qualitative interpretation of “‘In autimy- 
prognostic determinant. Because of the high specificity of osin images has to consider the variability of residual blood 
&timyosin antibody, this tracer would app& to be id&& flow in an infarct territory. Further clinical studies are 
suited for this oumose. Exoerimental (II) and clinical stud- rewired to define the relation of “‘In autimyosin uptake in 
Such an attempt was made by Johnson et al. (21), who 
. . . 
ies (8) have, in fact, demonstrated a correlation of antimyo- 
combined the use of thallium-20 and “‘In antimyosin as a 
means of risk stratification in patients with acute infarction. 
sin uptake to hintochemical and clinical corelates of infarct 
Their findings demonstrate that patients with thallium de- 
fects in areas remote from those of antimvosin uptake 
size. respectively. However, both studies involved a rep-x- 
(“mismatch”) had a greater risk for ischemic e&s than did 
fused state. No attampt to measure infarct size was made in 
patients with thallium defects in the same region as that of 
the multicenter trial in which a substantial number of sub- 
antimyosin uptake (“matched” defect). Many explanations 
can he made for these findings. Most plausible is that regions 
jecis had unsuccessful or no thrombolytic therapy. Hoa- 
of “mismatch” (thallium defect without antimyosin uptake) 
represent “ischemia at a distance” remote from the acute 
ever. our results, which demonstrate the dependence of 
infarction where the antimyosin uptake was noted. Such 
patients have been shown to have a graver clinical prognosis 
antimyosin uptake on blood flow, indicate a reduced poten- 
(22). Our resul& could also potentially explain the increased 
risk in these patients with “mismatches”; that is, thallium 
tial of this tracer for use in sizing infarcts except in conjunc- 
defects without autimyosin uptake could represent areas 
tion with a blood Row marker. 
with were ischemia that prevented antimyosin uptake. 
Thus, patients with an occluded infarct-related artery and no 
collateral perfusion may display a mismatch pattern. A 7. Johnson LL, Scldin DW. Becker IX. CI at. Andmy0sin irna& in acute 

